Skip to main content
. 2018 Apr 30;6(4):e104. doi: 10.2196/mhealth.9438

Table 2.

Effect of breast cancer e-support (BCS) program (intention-to-treat analysis) on primary and secondary outcomes at 3 months (T1) and 6 months (T2); N=114.

Treatment effect Mean (SD) Adjusted mean difference (95% CI) P valuea Effect size (Cohen d)

BCS+CAUb participants (n=57) CAU participants (n=57)


Primary outcomes





Self-efficacy (SICPAc) [19]






T1 227.12 (66.80) 197.07 (43.44) 21.05 (1.87 to 40.22) .03 0.53


T2 232.09 (69.01) 220.91 (56.32) 3.40 (−19.05 to 25.86) .76 0.18
Secondary outcomes





Social support (MSPSSd) [20]






T1 5.24 (1.00) 5.47 (2.75) −0.39 (−1.15 to 0.38) .32 −0.11


T2 5.62 (.65) 5.42 (.80) 0.14 (−0.13 to 0.41) .31 0.27

Symptom severity (MDASIe) [21]






T1 3.79 (1.81) 4.17 (1.71) −0.21 (−0.72 to 0.31) .42 −0.22


T2 3.67 (2.21) 4.30 (1.89) −0.26 (−0.88 to 0.36) .41 −0.31

Symptom interference (MDASI) [21]






T1 2.99 (1.78) 3.93 (1.91) −0.73 (−1.35 to −0.11) .02 0.51


T2 3.11 (2.01) 3.84 (1.95) −0.57 (−1.27 to 0.13) .11 −0.37

Quality of life (FACT-Bf) [22]






T1 92.87 (21.39) 84.09 (15.99) 6.64 (0.77 to 12.50) .03 0.46


T2 92.16 (21.24) 85.66 (15.58) 5.23 (−1.34 to 11.80) .12 0.35

Anxiety (HADSg) [23]






T1 9.93 (2.72) 10.28 (2.46) −0.77 (−1.62 to 0.08) .07 −0.14


T2 10.58 (2.87) 10.26 (2.39) −0.05 (−0.96 to 0.86) .92 0.12

Depression (HADS) [23]






T1 12.75 (1.57) 12.58 (2.15) 0.17 (−0.52 to 0.87) .62 0.09


T2 13.28 (2.02) 12.65 (2.53) 0.63 (−0.20 to 1.45) .14 0.28

aAll P values were calculated using an analysis of covariance with adjustment for baseline value of the corresponding questionnaire.

bCAU: care as usual.

cSICPA: Stanford Inventory of Cancer Patient Adjustment.

dMSPSS: Multidimensional Scale of Perceived Social Support.

eMDASI: MD Anderson Symptom Inventory.

fFACT-B: Functional Assessment of Cancer Treatment-B.

gHADS: Hospital Anxiety and Depression Scale.